Hülya Odabaşı Bükün

6PUBLICATIONS
44CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersAboriginal and Torres Strait Islander peoples and the law
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 09, 2026
Real-World Efficacy and Safety of Tyrosine Kinase Inhibitors in Patients With Advanced Bone Sarcomas: The TOGBONE Study of the Turkish Oncology Group.

|Jun 11, 2026
Association Between Blood Transfusion and Survival Outcomes in Metastatic Cutaneous Melanoma Treated with Nivolumab.

|Feb 27, 2026
Association of IMP3 and CD10 Expression with Clinicopathological Features and Outcomes in Phyllodes Tumors: A Retrospective Single-Center Study.

Hülya Odabaşı Bükün, Erdem Çubukçu, Adem Deligönül

|Feb 07, 2026
Internal carotid artery involvement and stroke risk in Takayasu arteritis: a case-control study.

Hulya Odabasi Bukun, Ugur Uygunoglu, Esra Firat Senturk

|Oct 29, 2025
Inflammatory and Nutritional Markers Predicting Pathological Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer: A Multicenter Real-World Study.

Zeliha Birsin, İsmail Nazlı, Onur Alkan

|Sep 27, 2025
Is Body Mass Index a Prognostic Factor in Metastatic HER2-Positive Breast Cancer? A Real-World Multicenter Study.

Zeliha Birsin, Hülya Odabaşı Bükün, İsmail Nazlı

Pageof 1

Frequent Collaborators

4 joint publications

Turkkan Evrensel

3 joint publications

Özkan Alan

3 joint publications

Ahmet Bilgehan Sahin

2 joint publications

Onur Alkan